Search results
Results From The WOW.Com Content Network
This is the list of Schedule II controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a high potential for abuse. The drug or other substance has a currently accepted medical use in ...
Ruan v. United States, No. 20-1410, 597 U.S. ___ (2022) The Controlled Substances Act ( CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug ...
The Drug Enforcement Administration is expected to approve an opinion by the Department of Health and Human Services that marijuana should be reclassified from the most strict Schedule I to the ...
In September 1988, after two years of extensive public hearings, DEA Chief Administrative Law Judge Francis L. Young ruled in favor of moving cannabis to a Schedule II classification, finding that "Marijuana, in its natural form, is one of the safest therapeutically active substances known to man."
In 1994, Senate Bill 1364 was approved by state legislators, to reclassify cannabis as a Schedule II drug at the state level. And Assembly Bill 1529 was approved in 1995, to create a medical necessity defense for patients using cannabis with a physician's recommendation, for treatment of AIDS, cancer, glaucoma, and multiple sclerosis.
The US Drug Enforcement Administration plans to reclassify marijuana as a less dangerous drug, a historic shift in US drug policy. At a federal level, marijuana is classified as a "Schedule I ...
Cannabis has been listed as a Schedule I drug - with no medicinal value and a high potential for addiction - for over 50 years, and that status served as the basis for decades of the War on Drugs.
The rescheduling of marijuana to a Schedule III drug would allow for further studies to be done. In a leaked HHS document , officials wrote to the DEA in support of rescheduling the drug.